Should You Buy Centene Corporation Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Centene Corporation (CNC) occupies a solid middle-ground position with a Quality of Company score of 7.4/10. At the current market price of $67.66, the investment case depends heavily on whether our 13 independent valuation models indicate a discount to fair value.
The short answer: 2 of 3 CirclFi valuation models project upside for Centene Corporation (CNC) at $67.66 — the model consensus leans bullish, with a Quality Score of 7.4/10 and Value-Trap risk of 13/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Centene Corporation (CNC) in 2026?
What Is the Bull Case vs the Bear Case for Centene Corporation (CNC)?
| Bull case — $194.50 target (+187.5%) | Bear case — $55.21 target (-18.4%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, Centene Corporation's quality score of 7.4/10 demonstrates the operational excellence that historically correlates with long-term shareholder value creation. | According to the CirclFi Deep Alpha Valuation Engine, the Earnings Power Value (EPV) model sees the stock as overvalued with a fair value of $55.21 (-18.4%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the gap between the market price of $67.66 and the median fair value of $132.46 implies +95.8% upside potential. | According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +205.9% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology. |
| According to the CirclFi Deep Alpha Valuation Engine, the FTNN Topology model targets a fair value of $194.50 (+187.5%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | Industry headwind: regulatory rejection risk represents a meaningful risk for Centene Corporation and its Healthcare Plans peers. |
| Industry tailwind: late-stage pipeline catalysts could provide meaningful support for Centene Corporation's revenue and margin trajectory in the Healthcare Plans space. |
How Does CNC Compare to Its Healthcare Plans Peers?
Valuation data pages: CVS · ALHC · HUM · OSCR · MOH · CLOV · PFHO · CI · PGNY
Which Other Stocks Score Like CNC on Quality?
Closest companies to CNC’s Quality of Company score of 7.4/10, across all industries.
- LAND — Gladstone Land Corporation (QOC 7.4) · analysis
- SCL — Stepan Company (QOC 7.4) · analysis
- SITM — SiTime Corporation (QOC 7.4) · analysis
- HGV — Hilton Grand Vacations Inc. (QOC 7.4) · analysis
- TACT — TransAct Technologies Incorporated (QOC 7.4) · analysis
- FNWD — Finward Bancorp (QOC 7.4) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
So Is Centene Corporation (CNC) Worth Buying in 2026?
Centene Corporation leans positive in our analysis — 2/3 models bullish, median fair value of $132.46 vs. $67.66, QOC 7.4/10. The case is constructive but not overwhelming, and the 1 dissenting model shouldn't be dismissed. Position sizing should reflect this moderate conviction level.
These are quantitative model outputs, not investment recommendations. Centene Corporation's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About CNC Stock?
Should I buy CNC stock right now?
Based on CirclFi's multi-model analysis, 2 of 3 models see upside for CNC at $67.66. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 7.4/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Centene Corporation?
Key risks include: limited model coverage (3/13 active), reducing analytical confidence; wide model disagreement (252% spread), signaling high uncertainty; general market and sector-specific risks affecting Healthcare Plans companies. Always diversify and consult a financial advisor.
How does CNC compare to its competitors?
Among Healthcare Plans peers, CNC holds a Quality Score of 7.4/10. Comparable companies include CVS (QOC 7.4), ALHC (QOC 7.2), HUM (QOC 7.6). The relative ranking helps investors identify whether CNC offers better fundamental quality than alternatives in the same sector.
Is CNC a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. CNC's Quality Score of 7.4/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy CNC at?
CirclFi does not provide target buy prices or price alerts. However, our 3 active models produce fair value estimates ranging from $55.21 to $194.50. At $67.66, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for CNC.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad